Skip to main content
G3: Genes | Genomes | Genetics logoLink to G3: Genes | Genomes | Genetics
. 2018 Nov 27;9(1):297–303. doi: 10.1534/g3.118.200795

Conditional Inactivation of Nf1 and Pten in Schwann Cells Results in Abnormal Neuromuscular Junction Maturation

Xiao-Xiao Li *,1, Shi-Jie Zhang *,†,‡,1, Amy P Chiu *, Lilian H Lo *, Jeffery C To *, He-Ning Cui *, Dewi K Rowlands §, Vincent W Keng *,2
PMCID: PMC6325916  PMID: 30478082

Abstract

The neuromuscular junction (NMJ) consists of three components, namely presynaptic motor neurons, postsynaptic muscle fibers and perisynaptic Schwann cells (PSCs). The role of Schwann cells (SCs) in regulating NMJ structural and functional development remains unclear. In this study, mice with conditional inactivation of neurofibromin 1 (Nf1) and phosphatase and tensin homolog (Pten), specifically in SCs, resulted in delayed NMJ maturation that led to delayed muscle growth, recapitulating the muscular dystrophy condition observed in human neurofibromatosis type I syndrome (NF1) patients. Expression levels of NMJ development related molecules such as cholinergic receptor, nicotinic, alpha polypeptide 1 (Chrna1), agrin (Agrn), dystrophin, muscular dystrophy (Dmd), laminin, beta 2 (Lamb2) and dystroglycan 1 (Dag1) were also downregulated. To further explore the molecular alterations in these SCs, NF1- and PTEN-related pathways were analyzed in mutant sciatic nerves. As expected, hyperactive RAS/PI3K/AKT/mTOR signaling pathways were identified, suggesting the importance of these pathways for NMJ development, and subsequent muscle maturation.

Keywords: neuromuscular junction, Schwann cell, Neurofibromin 1, phosphatase and tensin homolog


The NMJ involves a chemical synapse containing three components: presynaptic motor neurons where acetylcholine is synthesized and released; postsynaptic muscle fibers where the acetylcholine receptors (AChR) are enriched; and PSCs covering the connection of motor neurons and muscle fibers (Barik et al. 2016). Previous studies have focused primarily on the cooperating actions of motor nerve terminals and muscle fibers, as well as the underlying molecular mechanisms that mediate synaptic activities. Recently, PSCs have been reported to play an important role in NMJ development and its maintenance (Darabid et al. 2014). For example, compromised NMJ formation and maturation can result in severe muscle diseases, such as myasthenia gravis and congenital myasthenia syndromes (Engel et al. 2003).

The formation, maturation and maintenance of reliable synapses at the NMJ require dynamic molecular interactions among the three previously mentioned components. Prior to innervation of the muscle fiber by the motor neuron, clusters of nerve-independent AChR pre-patterning occurs in muscle fibers at around embryonic day 12.5 (Lin et al. 2001). Muscle fibers of the NMJ are poly-innervated, with more than one axon input for each muscle fiber. Following this NMJ formation is its maturation, during which synapse elimination as well as rearrangement of both pre- and post-synaptic elements occurs (Stevens et al. 2007; Darabid et al. 2014). The extracellular proteoglycan agrin (AGRN) has been well documented to have a pivotal role in AChR clustering, mainly caused by the interaction of lipoprotein receptor-related protein 4 (LRP4) and muscle, skeletal, receptor tyrosine kinase (MUSK) complex (Kim et al. 2008; Zhang et al. 2008). Mutant mice lacking Agrn displayed pre-synaptic abnormalities such as aberrant axonal branching and arborization, and post-synaptic AChR disorganization (Gautam et al. 1996), whereas mutant mice lacking either Lrp4 or Musk displayed severe and similar defects in AChR distribution (DeChiara et al. 1996; Weatherbee et al. 2006). Another extracellular molecule, neuregulin 1 (NRG1), promotes the biosynthesis of AChR proteins through binding of tyrosine kinase receptors from the epidermal growth factor receptor family (Ngo et al. 2012). In addition, WNT ligands are believed to be both positive and negative regulators of AChR aggregation and clustering via interactions with MUSK and AGRN (Budnik and Salinas 2011; Jing et al. 2009). Laminins are muscle-derived heterotrimeric glycoproteins and are major components in the NMJ basal lamina of the extracellular matrix. Mice lacking Lamb2 displayed fewer synaptic vesicles and active zones for neurotransmitter exocytosis, whereas SCs in Lamb2-deficient mice were able to invade into the synaptic cleft (Knight et al. 2003). It is therefore clear that the formation and maintenance of NMJ requires dedicate coordination of specific molecular interactions.

The role of SCs in regulating NMJ development and maturation has been previously reviewed, providing comprehensive knowledge of the relationship between SCs and the maturation of pre- and post-synaptic elements at the NMJ (Darabid et al. 2014). Mice lacking Nrg1, erb-b2 receptor tyrosine kinase 2 (Erbb2) or erb-b2 receptor tyrosine kinase 3 (Erbb3) display an aberrant NMJ phenotype, which may have been caused by the absence of SCs in these animal models (Lin et al. 2000; Wolpowitz et al. 2000). Additionally, spatial ablation of SCs before and after innervation in mice also distorted NMJ development and its maintenance, further confirming the role of SCs in NMJ development (Barik et al. 2016). However, the molecular mechanism(s) underlying the functional roles of SCs in NMJ development and maturation remains to be elucidated.

Nf1 and Pten are well-known tumor suppressor genes in different cancer types, and their co-mutations at specific tissues have been identified as the driver for tumor transformation (Keng et al. 2012; Chow et al. 2017). In our current study, mice with conditional inactivation of Nf1 and Pten, specifically in SCs, displayed severe movement disorders. The status of NMJ development and maturation was investigated by characterizing markers of both pre-synaptic neurofilament (NF) and post-synaptic AChR. Our results indicated that Nf1 and Pten inactivation in SCs delayed NMJ maturation at postnatal day 17 (P17). Expression of Chrna1, Dmd, Agrn, Lamb2 and Dag1 were all reduced in conditional Nf1 and Pten inactivated mice (desert hedgehog (Dhh)-Cre; Nf1flox/flox; Ptenflox/flox or DNT mice), which further confirmed a dysfunctional NMJ maturation phenotype. To further explore the molecular changes in mutant SCs, protein expression of NF1- and PTEN-related molecules were analyzed using mutant mouse sciatic nerves. Hyperactive RAS, PI3K, AKT and mTOR were identified in the sciatic nerves of DNT mice revealing that NF1 and PTEN, as well as RAS/PI3K/AKT/mTOR pathways in SCs play essential roles in regulating NMJ maturation.

Materials and Methods

Breeding strategy of DNT mice

Detailed breeding strategy of experimental mice cohorts can be found in our previous study (Keng et al. 2012). Primers used for genotyping of transgenes were performed as previously described (Keng et al. 2012). PCR bands representing different genotyping results of transgene combinations as shown in Figure 1A. All animal work was done under the regulation and guidelines of Centralized Animal Facility (CAF) and Animal Subjects Ethics Review (ASESC), The Hong Kong Polytechnic University, as well as The Laboratory Animal Services Centre (LASEC), The Chinese University of Hong Kong.

Figure 1.

Figure 1

Conditional Nf1 and Pten inactivation in SCs resulted in reduced musculature in DNT mice. (A) Genetic profile of Cre-loxP system in DNT mice, and representative PCR bands for the genotyping result of Dhh, Nf1 and Pten. tg, transgene; f, floxed allele; wt, wild-type allele. (B) Body length of all P17 mouse experimental cohorts: D, DN, DT and DNT. (C) Body weight of all P17 mouse experimental cohorts: D, DN, DT and DNT. Data expressed as mean ± SEM; **P < 0.01 (unpaired Student’s t-test); n = 7 mice per group. (D) Representative pictures of hind limbs from P17 D, DN, DT and DNT cohorts. Scale bars, 1cm.

Immunofluorescence staining of NMJ

Both hind limbs were dissected from P17 control and DNT mice following euthanasia by carbon dioxide. These harvested fresh limbs were fixed in 10% formalin (Sigma-Aldrich, Missouri, USA) with rotation overnight. Fixed limbs were rinsed three times for 30 min with phosphate buffered saline (PBS) (Life Technologies, California, USA) at room temperature. The tibialis anterior (TA) muscle was isolated from the fixed limbs and further teased into smaller muscle fibers under the dissecting microscope. Samples were placed in a 24-well plate and incubated in 0.1 M glycine diluted with PBS for one hour. To increase permeability, samples were rinsed three times with 0.5% Triton X-100 in PBS, 30 min for each rinse. The samples were then treated with blocking buffer (2.5% bovine serum albumin in 0.5% Triton X100/PBS) and incubated at either 4 hr at room temperature or overnight at 4°. Antibodies used for immunofluorescent microscopy were: neurofilament (NF), Alexa Fluor 555 Conjugate (Sigma-Aldrich) and AChR labeled using α-Bungarotoxin (α-BTX), Alexa Fluor 488 conjugate (Thermo Fisher Scientific, Massachusetts, USA). NF (1:500) and α-BTX (1:250) were added to samples and incubated for two days at 4°, then washed by rinsing three times, each for 1 hr, with 0.5% Triton X100/PBS. Muscle fiber samples were then placed on glass slides, followed by mounting with ProLong Antifade Kit (Thermo Fisher Scientific).

Quantitative RT-PCR

Muscle tissue from the hind limbs was homogenized in TRIzol reagent (Invitrogen, California, USA), using the Bertin Technologies Precellys Evolution Homogenizer. RNA was extracted following the manufacturer’s instructions. Complementary DNA (cDNA) was synthesized by using the PrimeScript RT Master Mix (TaKaRa Bio Inc., Kusatsu, Japan). Quantitative RT-PCR was conducted using GoTaq qPCR Master Mix (Promega, Wisconsin, USA). Ribosomal protein S20 (Rps20) was used as a reference gene to normalize the mRNA expression of Chrna1, Dmd, Agrn, Lamb2 and Dag1. The following primer pairs were used: Rps20-For, 5′- TGCTGAGGAACAAGTCGGTC-3′; Rps20-Rev, 5′- AGTCCGCACAAACCTTCTCC-3′; Chrna1-For, 5′-TATAACAACGCAGACGGCGA-3′; Chrna1-Rev, 5′-GCTGGTCACTTTCCGGGTTA-3′; Dmd-For, 5′- CTCACTGCCTGTGAAACCCT-3′; Dmd-Rev, 5′- CAGGCTCAAGAGATCCAAGCA-3′; Agrn-For, 5′- CTAGGGGAATCTCCGGTCCC-3′; Agrn-Rev, 5′- CCCATTAAGGCAGGGGTTGT-3′; Lamb2-For, 5′- ACCCACACGGTCGGGATG-3′; Lamb2-Rev, 5′- ACAGCCAGGTACATCCAAGG-3′; Dag1-For, 5′- GAGGGACTGGAAGAACCAGC-3′; Dag1-Rev, 5′- CCTGCTGCAGACACCTTGAT-3′.

Western blot analysis

Protein was extracted from sciatic nerves of experimental animals using the Qproteome Mammalian Protein Prep Kit (Qiagen, Hilden, Germany) following the manufacturer’s instructions. Protein concentrations were determined using the Bradford Protein Assay (Bio-Rad, California, USA). Protein samples were separated either on an 8% or 12% SDS-PAGE gel, before transferring to polyvinylidene difluoride (PVDF) membranes (MilliporeSigma, Massachusetts, USA). PVDF membranes were first incubated overnight with primary antibodies at 4°. Antibodies purchased from Cell Signaling Technology (Massachusetts, USA) and the dilutions used were as follows: AKT (1:2000), phospho-AKT (1:2000), PI3K (1:2000), phospho-PI3K (1:2000), phospho-mTOR (1:2000), RAS (1:2000) and ACTB (1:2000). This was followed by incubation with the corresponding secondary antibody at room temperature for one hour. Targeted bands were detected using a horseradish peroxidase-conjugated chemiluminescent kit (MilliporeSigma). ACTB was used as a loading control.

Data availability

The authors confirm that all data necessary for supporting the conclusions of the article are present within the article.

Results

Conditional inactivation of Nf1 and Pten in SCs resulted in reduced musculature

The DNT (Dhh-Cre; Nf1flox/flox; Ptenflox/flox) mice have been established as an animal model of malignant peripheral nerve sheath tumor in our previous study (Keng et al. 2012). In addition, DNT mice were smaller in size compared with control mice D (Dhh-Cre), single gene mutant mice DN (Dhh-Cre; Nf1flox/flox) and DT (Dhh-Cre; Ptenflox/flox) at postnatal day 7 (P7). However, there were no observable size differences between D and DT/DN mice. Most importantly, DNT mice have a tremoring phenotype, displayed difficulty in standing and obvious movement disability. This observation implies that DNT mice may have a deficit in muscle development and/or its maturation. DNT mice were killed at P17 before they became moribund and their body measurements taken (body length and weight). DNT mice were significantly shorter than control mice D, with an average body length of 4.6 cm and 6.4 cm, respectively (Figure 1B), while the body lengths of DN and DT mice had no significant differences compared with that of control mice D (Figure 1B). DNT mice had an average body weight of 4.1 g, while control D mice were on average 8.2 g (Figure 1C). The musculature of the DNT mice, including the limb muscles, diaphragm and heart were macroscopically reduced compared to control mice D (data not shown). The representative images of hind limb muscles taken from experimental and control cohorts are shown in Figure 1D.

Conditional inactivation of Nf1 and Pten in SCs induced NMJ maturation deficits

In order to investigate the underlying mechanism of the movement phenotype in DNT mice, the NMJ structure in mouse TA muscle was explored. NF conjugate Alexa Fluor 555 was used to label pre-synaptic axons, and α-BTX conjugate Alexa Fluor 488 was used to label the post-synaptic AChRs. NMJ morphology of P17 DNT mice revealed distorted AChR clusters and delayed synapse elimination, indicating a delay in NMJ synapse maturation (Figure 2A). In DNT mice, the average AChR endplate was 139.6 µm2 in size, compared with 263.6 µm2 for control mice D (Figure 2B). AChR-enriched postsynaptic elements are ovoid plaque shaped at P1, followed by perforation with a lower density of AChR clusters and branched AChR clusters during the first two weeks of early postnatal age (Sanes and Lichtman 2001; Marques et al. 2000). Therefore, the transition of ovoid plaque to branched pretzel-shape of AChR clusters is indicative of the NMJ maturation process. The percentage of branched AChR clusters in DNT mice were dramatically reduced compared to that in control mice D (Figure 2C). Instead, increased plaque shaped and perforated endplates in DNT mice were observed (Figure 2C), indicating a delayed endplate maturation phenotype. In addition, the percentage of poly-innervated AChRs increased, indicating a delayed synapse elimination phenotype (Figure 2D). Taken together, these results imply that NMJ maturation was delayed in DNT mice.

Figure 2.

Figure 2

NMJ maturation deficits in TA muscle of DNT mice. (A) Representative confocal images of TA muscles from P17 D and DNT mice. Teased TA muscles were stained with NF conjugate Alexa Fluor 555 to label pre-synaptic axon, and α-BTX conjugate Alexa Fluor 488 for visualization of AChR clustering. Scale bars, 10 µm. (B to D) Quantitative analyses of the AChR cluster size (B), AChR morphology (C) and NMJ innervation (D). Data expressed as mean ± SEM; **P < 0.01 (unpaired Student’s t-test).

Molecular confirmation of NMJ maturation deficits in the TA muscle of DNT mice

To further study the effects of Nf1 and Pten inactivation on NMJ growth, Chrna1, Dmd, Agrn, Lamb2 and Dag1 were analyzed using RNA extracted from both TA muscle and diaphragm. Chrna1 gene (also known as Achr-1) encodes for an alpha subunit of the muscle-derived nicotinic acetylcholine receptor, which also serves as a marker for post-synaptic muscle fiber. DMD connects transmembrane components of the dystrophin-glycoprotein complex to the intracellular cytoskeleton network (Gao and McNally 2011). Mice lacking Dmd displayed NMJ malformation and subsequent muscle dystrophy (Shiao et al. 2004). Agrn and synaptic basal lamina, especially Lamb2, are essential for pre- and post-synaptic maturation and maintenance of NMJ (Nishimune et al. 2008; Gautam et al. 1996). DAG1 works as a transmembrane protein, linking it to the ECM (Smith et al. 2013). DAG1 also acts as a receptor for laminin and AGRN in the regulation of nerve-induced AChR clustering formation (Tremblay and Carbonetto 2006). In our study, mRNA expression of Chrna1 was reduced in DNT mice (Figure 3A and 3B), consistent with the smaller endplate size (Figure 2B). The expression of Dmd, Agrn, Lamb2 and Dag1 in TA muscle (Figure 3A) and diaphragm (Figure 3B) were reduced in DNT mice compared with that in control mice D. Taken together, these results strongly suggest dysfunctional NMJ maturation in DNT mice.

Figure 3.

Figure 3

Molecular confirmation of NMJ maturation deficits in DNT mice. Expression levels of Chrna1, Dmd, Agrn, Lamb2 and Dag1 were reduced in TA muscle (A) and diaphragm (B) of DNT mice by quantitative real-time PCR. Data expressed as mean ± SEM of three independent experiments. *P < 0.05 and **P < 0.01 (unpaired Student’s t-test).

Activated RAS/PI3K/AKT/mTOR pathways in sciatic nerves of DNT mice

In order to elucidate the molecular mechanism(s) caused by Nf1 and Pten inactivation in SCs, protein expression was evaluated using the protein lysate taken from sciatic nerves of mutant DNT mice. It has been reported that NF1 is a negative regulator of RAS and its mutation induces RAS activation, as well as downstream PI3K signaling pathway (Bollag et al. 1996). As expected, RAS and PI3K phosphorylation were increased in DNT mice (Figure 4A and 4B). PTEN works as a negative mediator of AKT, therefore its mutation results in activated AKT phosphorylation (Stambolic et al. 1998). AKT phosphorylation and its downstream mTOR signaling pathway were significantly upregulated in DNT mice compared with that of control mice D (Figure 4A and 4B). These results suggest that Nf1 and Pten inactivation in SCs induce hyperactive RAS/PI3K/AKT/mTOR pathways, affecting NMJ maturation in DNT mice.

Figure 4.

Figure 4

Activation of RAS/PI3K/AKT/mTOR pathways in sciatic nerves of DNT mice. (A) Representative Western blots showing significantly higher levels of RAS, phosphorylated PI3K (pPI3K), phosphorylated AKT (pAKT) and phosphorylated mTOR (p-mTOR) in DNT compared with control D cohorts. (B) Semi-quantitative analyses of Western blots. RAS and p-mTOR levels relative to ACTB; while pPI3K and pAKT levels relative to total PI3K and total AKT levels, respectively. Data expressed as mean ± SEM of three independent blots. *P < 0.05 and **P < 0.01 (unpaired Student’s t-test).

Discussion

In this study, characterization and molecular alterations underlying the NMJ abnormalities were evaluated in mice with conditional inactivation of Nf1 and Pten genes, specifically in SCs. In addition, NF1 and PTEN related RAS/PI3K/AKT/mTOR pathways in SCs were proven to have a pivotal role in regulating NMJ maturation.

DNT mice have a short lifespan of around P18-20 days, as these mice were reported to bear high grade malignant peripheral nerve sheath tumors (Keng et al. 2012). Importantly, the tremoring, difficulty in movement and runty phenotype can be observed as early as P7. Comparing with control mice (D, DN and DT), the heart and diaphragm from DNT mice were significantly smaller at P17 (data not shown), indicating these mice may also has a severe muscle developmental disorder, contributing to its short lifespan. Clinically, patients with NF1 are reported to have reduced skeletal muscle size, muscle weakness and motor function deficits due to nerve dysfunction (Summers et al. 2015). These symptoms are highly consistent with the muscle phenotype of DNT mice but the detailed mechanism(s) underlying the movement disorders are largely unknown. Recently, SCs have drawn much attention regarding their role in regulating NMJ development (Darabid et al. 2014; Barik et al. 2016). Based on these previous studies, we hypothesized that conditional inactivation of Nf1 and Pten in SCs could also affect NMJ development and subsequent muscle growth/maturation.

To further explore this, the body length and weight of all experimental mice were examined. The body length and weight of DNT mice were significantly reduced compared with either control mice D or single gene mutated mice DN/DT (Figure 1B and 1C). A reduction in musculature was observed in DNT mice but not in DN or DT mice, indicating synergistic effects of Nf1- and Pten-deficiency in SCs contributing to muscle dystrophy (Figure 1D). Since SCs have been shown to be involved in AChR cluster maturation and maintenance (Barik et al. 2016), the NMJ structure in DNT mouse TA muscle was also investigated. Compared with control mice D, the NMJ phenotype in DNT mice included an AChR endplate size reduction and the percentage of branched endplate and mature single innervated endplate were decreased (Figure 2). In addition, molecules known to be key markers and mediators in NMJ development such as Chrna1, Dmd, Agrn, Lamb2 and Dag1 (Nishimune et al. 2008; Jacobson et al. 2001; Davies and Nowak 2006) were also decreased in DNT mice compared with that of control group D (Figure 3). Importantly, SCs have been shown to be a source for AGRN, WNT ligands, NRG1 and TGFB (Darabid et al. 2014). Dysfunctional SCs could therefore account for the abnormal NMJ maturation observed in DNT mice.

However, it remains unclear which different roles the myelinating SCs and PSCs (non-myelinating Schwann cells) may play in the NMJ maturation process. It has been shown that targeting PSCs in mice using anti-disialoside antibodies from patients have resulted in both morphological and functional changes in NMJ (Halstead et al. 2004). In addition, PSCs are believed to participate in NMJ remodeling after nerve injury by guiding the reinnervation of axons (Kang et al. 2014). In addition, the AKT/mTOR pathway has been shown to regulate myelination development in the peripheral nervous system (Domènech-Estévez et al. 2016; Norrmén and Suter 2013). PTEN reduction in both oligodendrocytes and SCs induced hypermyelination while its activation resulted in blocked myelination (Goebbels et al. 2010). Other molecules such as phosphatidylinositol 4-kinase alpha and fatty acid synthase have been reported to cause aberrant myelination (Alvarez-Prats et al. 2018; Montani et al. 2018), which suggests that the AKT/mTOR pathway can affect the myelination of SCs and influence the actions of neurons. Therefore, the exact roles of myelinating SCs and PSCs in NMJ development remains unclear. Further studies should be conducted in order to elucidate the regulatory effects of specific SCs in NMJ development and maturation. It has also been demonstrated the ablation of SCs can influence NMJ maturation and its maintenance, but the exact mechanism involved with this also remains elusive (Barik et al. 2016).

Finally, our current study demonstrates that hyperactive RAS/PI3K/AKT/mTOR pathways in SCs could disrupt expression of basal laminin molecules including Agrn, lamb2, Dag1, Chrna1 and Dmd, resulting in delayed NMJ maturation. This study therefore provides additional genetic understanding to the role of SCs in NMJ development and maturation.

Acknowledgments

This study was supported by Department of Applied Biology and Chemical Technology (G-YBTA) and Faculty of Applied Science and Textiles (1-ZVLC), The Hong Kong Polytechnic University, Hong Kong SAR. The authors declare no competing interests.

Footnotes

Communicating editor: D. Fay

Literature Cited

  1. Alvarez-Prats A., Bjelobaba I., Aldworth Z., Baba T., Abebe D., et al. , 2018.  Schwann-Cell-Specific Deletion of Phosphatidylinositol 4-Kinase Alpha Causes Aberrant Myelination. Cell Reports 23: 2881–2890. 10.1016/j.celrep.2018.05.019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barik A., Li L., Sathyamurthy A., Xiong W.-C., Mei L., 2016.  Schwann cells in neuromuscular junction formation and maintenance. J. Neurosci. 36: 9770–9781. 10.1523/JNEUROSCI.0174-16.2016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bollag G., Clapp D. W., Shih S., Adler F., Zhang Y. Y., et al. , 1996.  Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells. Nat. Genet. 12: 144–148. 10.1038/ng0296-144 [DOI] [PubMed] [Google Scholar]
  4. Budnik V., Salinas P. C., 2011.  Wnt signaling during synaptic development and plasticity. Curr. Opin. Neurobiol. 21: 151–159. 10.1016/j.conb.2010.12.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chow R. D., Guzman C. D., Wang G., Schmidt F., Youngblood M. W., et al. , 2017.  AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma. Nat. Neurosci. 20: 1329–1341. 10.1038/nn.4620 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Darabid H., Perez-Gonzalez A. P., Robitaille R., 2014.  Neuromuscular synaptogenesis: coordinating partners with multiple functions. Nat. Rev. Neurosci. 15: 703–718. 10.1038/nrn3821 [DOI] [PubMed] [Google Scholar]
  7. Davies K. E., Nowak K. J., 2006.  Molecular mechanisms of muscular dystrophies: old and new players. Nat. Rev. Mol. Cell Biol. 7: 762–773. 10.1038/nrm2024 [DOI] [PubMed] [Google Scholar]
  8. DeChiara T. M., Bowen D. C., Valenzuela D. M., Simmons M. V., Poueymirou W. T., et al. , 1996.  The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo. Cell 85: 501–512. 10.1016/S0092-8674(00)81251-9 [DOI] [PubMed] [Google Scholar]
  9. Domènech-Estévez E., Baloui H., Meng X., Zhang Y., Deinhardt K., et al. , 2016.  Akt regulates axon wrapping and myelin sheath thickness in the PNS. J. Neurosci. 36: 4506–4521. 10.1523/JNEUROSCI.3521-15.2016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Engel A. G., Ohno K., Sine S. M., 2003.  Sleuthing molecular targets for neurological diseases at the neuromuscular junction. Nat. Rev. Neurosci. 4: 339–352. 10.1038/nrn1101 [DOI] [PubMed] [Google Scholar]
  11. Gao Q. Q., McNally E. M., 2011.  The dystrophin complex: structure, function, and implications for therapy. Compr. Physiol. 5: 1223–1239. 10.1002/cphy.c140048 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gautam M., Noakes P. G., Moscoso L., Rupp F., Scheller R. H., et al. , 1996.  Defective neuromuscular synaptogenesis in agrin-deficient mutant mice. Cell 85: 525–535. 10.1016/S0092-8674(00)81253-2 [DOI] [PubMed] [Google Scholar]
  13. Goebbels S., Oltrogge J. H., Kemper R., Heilmann I., Bormuth I., et al. , 2010.  Elevated phosphatidylinositol 3, 4, 5-trisphosphate in glia triggers cell-autonomous membrane wrapping and myelination. J. Neurosci. 30: 8953–8964. 10.1523/JNEUROSCI.0219-10.2010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Halstead S. K., O’hanlon G. M., Humphreys P. D., Morrison D. B., Morgan B. P., et al. , 2004.  Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy. Brain 127: 2109–2123. 10.1093/brain/awh231 [DOI] [PubMed] [Google Scholar]
  15. Jacobson C., Côté P. D., Rossi S. G., Rotundo R. L., Carbonetto S., 2001.  The dystroglycan complex is necessary for stabilization of acetylcholine receptor clusters at neuromuscular junctions and formation of the synaptic basement membrane. J. Cell Biol. 152: 435–450. 10.1083/jcb.152.3.435 [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Jing L., Lefebvre J. L., Gordon L. R., Granato M., 2009.  Wnt signals organize synaptic prepattern and axon guidance through the zebrafish unplugged/MuSK receptor. Neuron 61: 721–733. 10.1016/j.neuron.2008.12.025 [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kang H., Tian L., Mikesh M., Lichtman J. W., Thompson W. J., 2014.  Terminal Schwann cells participate in neuromuscular synapse remodeling during reinnervation following nerve injury. J. Neurosci. 34: 6323–6333. 10.1523/JNEUROSCI.4673-13.2014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Keng V. W., Rahrmann E. P., Watson A. L., Tschida B. R., Moertel C. L., et al. , 2012.  PTEN and NF1 inactivation in Schwann cells produces a severe phenotype in the peripheral nervous system that promotes the development and malignant progression of peripheral nerve sheath tumors. Cancer Res. 72: 3405–3413. 10.1158/0008-5472.CAN-11-4092 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kim N., Stiegler A. L., Cameron T. O., Hallock P. T., Gomez A. M., et al. , 2008.  Lrp4 is a receptor for Agrin and forms a complex with MuSK. Cell 135: 334–342. 10.1016/j.cell.2008.10.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Knight D., Tolley L. K., Kim D. K., Lavidis N. A., Noakes P. G., 2003.  Functional analysis of neurotransmission at β2‐laminin deficient terminals. J. Physiol. 546: 789–800. 10.1113/jphysiol.2002.030924 [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lin W., Burgess R. W., Dominguez B., Pfaff S. L., Sanes J. R., et al. , 2001.  Distinct roles of nerve and muscle in postsynaptic differentiation of the neuromuscular synapse. Nature 410: 1057–1064. 10.1038/35074025 [DOI] [PubMed] [Google Scholar]
  22. Lin W., Sanchez H. B., Deerinck T., Morris J. K., Ellisman M., et al. , 2000.  Aberrant development of motor axons and neuromuscular synapses in erbB2-deficient mice. Proc. Natl. Acad. Sci. USA 97: 1299–1304. 10.1073/pnas.97.3.1299 [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Marques M. J., Conchello J.-A., Lichtman J. W., 2000.  From plaque to pretzel: fold formation and acetylcholine receptor loss at the developing neuromuscular junction. J. Neurosci. 20: 3663–3675. 10.1523/JNEUROSCI.20-10-03663.2000 [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Montani L., Pereira J. A., Norrmén C., Pohl H. B., Tinelli E., et al. , 2018.  De novo fatty acid synthesis by Schwann cells is essential for peripheral nervous system myelination. J. Cell Biol. 217: 1353–1368. 10.1083/jcb.201706010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Ngo S. T., Cole R. N., Sunn N., Phillips W. D., Noakes P. G., 2012.  Neuregulin-1 potentiates agrin-induced acetylcholine receptor clustering through muscle-specific kinase phosphorylation. J. Cell Sci. 125: 1531–1543. 10.1242/jcs.095109 [DOI] [PubMed] [Google Scholar]
  26. Nishimune H., Valdez G., Jarad G., Moulson C. L., Müller U., et al. , 2008.  Laminins promote postsynaptic maturation by an autocrine mechanism at the neuromuscular junction. J. Cell Biol. 182: 1201–1215. 10.1083/jcb.200805095 [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Norrmén C., Suter U., 2013.  Akt/mTOR Signalling in Myelination. Portland Press Limited, London: 10.1042/BST20130046 [DOI] [Google Scholar]
  28. Sanes J. R., Lichtman J. W., 2001.  Induction, assembly, maturation and maintenance of a postsynaptic apparatus. Nat. Rev. Neurosci. 2: 791–805. 10.1038/35097557 [DOI] [PubMed] [Google Scholar]
  29. Shiao T., Fond A., Deng B., Wehling-Henricks M., Adams M. E., et al. , 2004.  Defects in neuromuscular junction structure in dystrophic muscle are corrected by expression of a NOS transgene in dystrophin-deficient muscles, but not in muscles lacking α-and β1-syntrophins. Hum. Mol. Genet. 13: 1873–1884. 10.1093/hmg/ddh204 [DOI] [PubMed] [Google Scholar]
  30. Smith L. R., Meyer G., Lieber R. L., 2013.  Systems analysis of biological networks in skeletal muscle function. Wiley Interdiscip. Rev. Syst. Biol. Med. 5: 55–71. 10.1002/wsbm.1197 [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Stambolic V., Suzuki A., De La Pompa J. L., Brothers G. M., Mirtsos C., et al. , 1998.  Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95: 29–39. 10.1016/S0092-8674(00)81780-8 [DOI] [PubMed] [Google Scholar]
  32. Stevens B., Allen N. J., Vazquez L. E., Howell G. R., Christopherson K. S., et al. , 2007.  The classical complement cascade mediates CNS synapse elimination. Cell 131: 1164–1178. 10.1016/j.cell.2007.10.036 [DOI] [PubMed] [Google Scholar]
  33. Summers M., Quinlan K., Payne J., Little D., North K., et al. , 2015.  Skeletal muscle and motor deficits in Neurofibromatosis Type 1. J. Musculoskelet. Neuronal Interact. 15: 161. [PMC free article] [PubMed] [Google Scholar]
  34. Tremblay M. R., Carbonetto S., 2006.  An extracellular pathway for dystroglycan function in acetylcholine receptor aggregation and laminin deposition in skeletal myotubes. J. Biol. Chem. 281: 13365–13373. 10.1074/jbc.M600912200 [DOI] [PubMed] [Google Scholar]
  35. Weatherbee S. D., Anderson K. V., Niswander L. A., 2006.  LDL-receptor-related protein 4 is crucial for formation of the neuromuscular junction. Development 133: 4993–5000. 10.1242/dev.02696 [DOI] [PubMed] [Google Scholar]
  36. Wolpowitz D., Mason T. B., Dietrich P., Mendelsohn M., Talmage D. A., et al. , 2000.  Cysteine-rich domain isoforms of the neuregulin-1 gene are required for maintenance of peripheral synapses. Neuron 25: 79–91. 10.1016/S0896-6273(00)80873-9 [DOI] [PubMed] [Google Scholar]
  37. Zhang B., Luo S., Wang Q., Suzuki T., Xiong W. C., et al. , 2008.  LRP4 serves as a coreceptor of agrin. Neuron 60: 285–297. 10.1016/j.neuron.2008.10.006 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The authors confirm that all data necessary for supporting the conclusions of the article are present within the article.


Articles from G3: Genes|Genomes|Genetics are provided here courtesy of Oxford University Press

RESOURCES